Hypertension, defined by sustained elevated blood pressure levels, is a leading risk factor for cardiovascular morbidity and mortality worldwide. In older adults, the condition’s management becomes increasingly labyrinthine due to age-related physiological changes, comorbidities, and polypharmacy. Effective self-management behaviors—ranging from medication adherence to lifestyle modifications—are critical levers in mitigating risk. However, these behaviors are neither spontaneous nor uniform; they are the products of a complex interplay of knowledge, beliefs, motivation, and contextual factors. Li and Cheng seek to decode these interactions through the lens of the PRECEDE–PROCEED model, a comprehensive health promotion planning framework grounded in social and behavioral science.

The PRECEDE–PROCEED model divides the evaluation of health behavior determinants into multiple phases, ranging from social assessment to outcome evaluation. In this study, the researchers focus on delineating predisposing, enabling, and reinforcing factors that underpin hypertension self-management behaviors. Predisposing factors include internal elements such as knowledge and attitudes, enabling factors encompass external resources and skills facilitating action, and reinforcing factors involve feedback and support from social environments. By mapping these dimensions, Li and Cheng’s path analysis exposes how each domain contributes directly and indirectly to self-management adherence among the elderly.

Crucially, the study situates older adults within their social milieus, recognizing that self-management is embedded within broader social contexts. Family support networks, healthcare provider relationships, and community resources emerge as pivotal reinforcing factors in sustaining hypertension control efforts. The investigation reveals that social reinforcement compounds the effect of individual motivation, enhancing behavioral persistence. This finding aligns with existing literature but extends it by quantifying the magnitude of influence through structural equation modeling, thereby offering robust empirical grounding.

Li and Cheng’s methodology involved a comprehensive survey of older hypertensive patients, capturing psychosocial variables and self-reported management behaviors. The data fed into a sophisticated path analysis test, evaluating direct and mediated relationships among constructs elaborated by the PRECEDE–PROCEED framework. The robust statistical approach strengthens causal inference, moving beyond correlation to identify viable intervention points. The novelty of employing path analysis within this theoretical context enhances the granularity of insights regarding behavior change determinants in an aging population.

One of the standout observations from the study is the pivotal role of knowledge as a predisposing factor. While knowledge alone does not guarantee behavior modification, it functions as a gateway, influencing attitudes and perceptions that predispose individuals toward or away from self-care. The researchers note substantial variability in knowledge levels about hypertension among participants, underlining persistent educational gaps. This suggests that tailored information dissemination remains a key priority for healthcare providers seeking to empower older adults effectively.

Moreover, enabling factors such as access to health services, medication affordability, and practical skills for monitoring blood pressure surfaced as significant pathways for self-management adherence. The findings emphasize that structural barriers can undermine motivation and knowledge gains if not simultaneously addressed. Therefore, interventions must be multidimensional, combining education with systemic enhancements to facilitate actionable behavior changes. This perspective advances health policy dialogues by integrating psychosocial and infrastructural components into chronic disease management frameworks.

The reinforcing factors component underscores the vital contribution of interpersonal relationships and community engagement in sustaining hypertension control efforts. Support from family members, peer groups, and healthcare professionals acts as a behavioral catalyst, providing encouragement, accountability, and reminders. Li and Cheng’s analysis quantifies this support’s impact, illustrating that enhancing social reinforcement mechanisms could yield substantial improvements in treatment adherence and blood pressure outcomes among older adults.

Importantly, the study identifies feedback loops within the behavioral pathway, illustrating how successful self-management behaviors can strengthen reinforcing mechanisms, creating a virtuous cycle of health engagement. Conversely, barriers encountered during self-care can precipitate negative feedback, deterring sustained adherence. This dynamic perspective is instrumental in designing interventions that remain adaptive and responsive to patient experiences, a fundamental consideration for longitudinal chronic disease management.

The application of the PRECEDE–PROCEED framework also facilitates the development of theoretically informed and practically relevant intervention modules. By characterizing the distinct traits of predisposing, enabling, and reinforcing factors, the study guides targeted strategies such as personalized education programs, resource facilitation, and social support strengthening. This theoretically attuned approach surpasses generic intervention models, promising enhanced efficacy through relevance and precision tailored to older adults’ unique needs.

Furthermore, Li and Cheng’s research offers implications extending beyond hypertension, suggesting that the multilevel pathway approach may be generalizable to other chronic conditions prevalent in aging populations. The intricate interaction between individual cognition, environmental contexts, and social dynamics is a common thread across various diseases requiring self-management. Their work exemplifies how integrating health behavior theory with empirical methods can yield replicable models useful in diverse clinical and public health scenarios.

This study’s relevance escalates in light of demographic transitions marked by increasing longevity and chronic disease prevalence. Hypertension’s global burden disproportionately affects older adults, imposing significant healthcare costs and quality-of-life detriments. Li and Cheng’s evidence-based insights contribute foundational knowledge essential for crafting interventions capable of reducing these burdens. Their path analysis holds promise for informing public health programs, clinical guidelines, and policy frameworks prioritizing patient-centered, theory-driven hypertension management.

Technically, the reliance on structural equation modeling illustrates an advanced analytical paradigm that offers granular insight into multifactorial relationships often obscured in simpler statistical analyses. The ability to model latent constructs and pathways simultaneously enhances understanding of indirect effects and complex mediators involved in health behaviors. This methodological rigor secures the study’s position as a benchmark for future research exploring psychosocial determinants of chronic disease self-care.

Moreover, the intersection of behavioral science and gerontology spotlighted in this research is pivotal. Older adults present a heterogenous group with diverse psychosocial profiles and healthcare challenges. The use of the PRECEDE–PROCEED model acknowledges this complexity, embracing multifaceted influences rather than reductive cause-effect attributions. This comprehensive viewpoint is essential for generating interventions that resonate with real-world experiences, thus enhancing adoption and sustainability of health-promoting behaviors among seniors.

In summary, Li and Cheng’s 2026 publication elucidates the nuanced pathways shaping hypertension self-management among older adults through a sophisticated, theory-driven path analysis. The findings underscore the multifactorial nature of behavior and highlight strategic leverage points for intervention development. By bridging theory and practice with statistical precision, their work advances the science of chronic disease self-care and sets a new standard for geriatric health research. This research not only deepens understanding but also charts a promising course for improving outcomes in an era defined by aging societies and chronic health challenges.

Subject of Research: Hypertension self-management behaviors among older adults

Article Title: Pathways associated with hypertension self-management behaviors among older adults: a PRECEDE–PROCEED theory-guided path analysis

Article References:
Li, J., Cheng, J. Pathways associated with hypertension self-management behaviors among older adults: a PRECEDE–PROCEED theory-guided path analysis. BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-07842-8

Image Credits: AI Generated

DOI: 10.1186/s12877-026-07842-8

Keywords: hypertension, self-management, older adults, PRECEDE-PROCEED model, path analysis, chronic disease management, behavioral theory, structural equation modeling

Breast cancer remains one of the most prevalent forms of cancer among women globally, with HER2-positive and triple-negative breast cancers representing particularly aggressive subtypes. The dynamics of treatment for these types often involve complex decisions—introduction of chemotherapy, targeted therapies, and participation in clinical trials—which can become more nuanced with advancing age. Data from the recent study suggests that older patients often face more barriers when it comes to understanding and weighing their treatment choices against potential side effects, specifically the intersection of polypharmacy, comorbidities, and psychosocial factors that often accompany advanced age.

Interestingly, the study found that older patients exhibit a unique set of preferences concerning the risks and benefits of treatment options. For example, many older patients reported favoring less aggressive treatments, prioritizing quality of life over the length of survival. This departure from traditional oncological prioritization emphasizes the necessity for healthcare providers to engage in more thorough conversations about the goals of care with their older patients. Such discussions need to cover not just the practical aspects of treatment, but also how these treatments may align with the patients’ personal values and life goals.

Central to this research is the nuanced relationship between age and cognitive function, an aspect that can heavily influence decision-making abilities. The cognitive decline often experienced with age can hinder patients’ capacity to process complex medical information. Consequently, tailored communication strategies may be essential in ensuring that older patients can fully grasp their treatment options. This finding points to the role of healthcare professionals in adapting their communication techniques, ensuring that they engage older patients in a manner that fosters understanding and encourages active participation in their care decisions.

The implications of this research extend beyond individual patient experiences; they also spark discussions about the broader medical policies that govern treatment for older adults with aggressive cancers. The study argues for a more age-conscious approach in clinical guidelines and treatment protocols, advocating for healthcare systems to provide resources that enable medical teams to better support older patients in the decision-making process. This change could have substantial implications for insurance coverage, clinical trial eligibility, and access to comprehensive geriatric assessment tools.

Moreover, the emotional and psychological impacts of receiving a cancer diagnosis can amplify the need for supportive resources for older patients. Through elucidating the various barriers and preferences, healthcare institutions may begin to recognize the potential necessity for dedicated support staff who can assist these patients in navigating the emotional landscape that often accompanies cancer treatment. Addressing mental health is crucial, as feelings of isolation and hopelessness can affect treatment adherence and overall outcomes.

As ongoing research sheds light on the unique requirements of older patients with breast cancer, a transformation in how we view age-related factors in healthcare is expected. Recognition that older patients have distinct needs can pave the way for enhanced treatment strategies that prioritize not just survival rates but patients’ quality of life and satisfaction with their care. Emphasis on personalized care for older adults is paramount and is anticipated to become a cornerstone of oncology practice in the coming years.

In sum, the findings from this study contribute significantly to the growing body of literature advocating for a shift in how oncology is practiced toward older populations. The interplay of age, decision-making, and breast cancer treatment shines a spotlight on the neglect this demographic often faces in clinical settings. The research encapsulates the essence of patient-centered care, underscoring that treatment should start with understanding patients—especially older ones—as individuals with unique life experiences, values, and preferences.

As healthcare continues to evolve, the ongoing dialogue surrounding age and treatment decision-making can only serve to enrich our understanding of personalized cancer care. Ultimately, integrating these insights could lead to better outcomes for older patients, minimizing the risk of overtreatment and fostering a healthcare environment where older patients feel respected, heard, and invested in their treatment journeys.

The call for change in oncology is clear: age must be considered a crucial determinant in the decision-making process for treatment of aggressive cancers like HER2-positive and triple-negative breast cancer, as older patients are not only living longer thanks to advances in medicine but deserve to do so with dignity, understanding, and autonomy.

Subject of Research: Age as a determining factor in decision-making for older patients with HER2-positive and triple-negative breast cancer.

Article Title: Age as a determining factor in decision-making in older patients with HER2-positive and triple-negative breast cancer.

Article References:

Otero-Romero, D., Medina-Mora, L., Carramiñana-Nuño, R. et al. Age as a determining factor in decision-making in older patients with HER2-positive and triple-negative breast cancer.
Eur Geriatr Med (2025). https://doi.org/10.1007/s41999-025-01380-z

Image Credits: AI Generated

DOI: 18 December 2025

Keywords: Age, decision-making, older patients, HER2-positive breast cancer, triple-negative breast cancer, quality of life, oncology, treatment choices.

With the growing population of older adults worldwide, there is an increasing need for effective strategies to ensure safer prescribing practices. This necessity has resulted in the continuous development and refinement of criteria like STOPP/START. The recent work by Dalleur and colleagues illuminates the complexities involved in optimizing these criteria, which are often underutilized despite their clear benefits in clinical settings. The researchers meticulously assessed the current version of these criteria, identifying specific pain points in user engagement and how practitioners interact with the tool.

One of the critical findings highlighted in the study is that the initial format and presentation of the STOPP/START criteria do not lend themselves to intuitive use during clinical decision-making. This lack of user-friendliness can lead to lower adherence rates among healthcare providers, meaning that potential benefits for patients could be overlooked. To address this, the team focused on redesigning the tool to make it more accessible and straightforward, ensuring it aligns with the daily workflows and cognitive demands of healthcare professionals.

The research team utilized a comprehensive approach that included collaborative feedback from various stakeholders, including clinicians, pharmacy students, and geriatric specialists. This approach ensured that multiple perspectives and types of expertise were incorporated during the redesign phase. As a result, the practice tool developed not only improves usability but also enhances clinical effectiveness by being more attuned to feedback from actual users in the field.

In creating this user-centric tool, the researchers tested various formats and presentation styles. They explored incorporating user-friendly interfaces, decision trees, and algorithmic approaches to aid practitioners in quickly identifying appropriate prescribing practices for their elderly patients. They also focused on creating a learning platform that can be easily accessed and taught to students, thus fostering a culture of safe prescribing from the early stages of medical education.

Furthermore, the study elucidated the implications of effective communication in medication management. A significant observation was that many healthcare providers struggle with information overload when assessing multiple chronic conditions and medications. Thus, the reformulated practice tool emphasizes clarity and simplicity, aiming to break down complex information into digestible segments that can be rapidly assessed in clinical settings.

In addition to the usability aspect, this study emphasizes the importance of continual education and training for healthcare providers regarding polypharmacy management. By developing a supportive educational tool alongside the criteria, the research helps bridge the gap between theoretical knowledge and practical application in real-life situations. This approach not only enhances the immediate work environment for clinicians but also ultimately benefits patient safety and health outcomes.

Elderly patients are particularly vulnerable to adverse drug events due to physiological changes associated with aging, interactions between drugs, and the presence of multiple medications. Thus, this redesign certainly comes at a critical time when healthcare systems globally face challenges in appropriately managing elderly care.

The ongoing discourse surrounding the health and medication needs of older adults has underscored the urgency of initiatives like this one. By producing a more refined version of the STOPP/START criteria, this project represents a concerted effort to promote safe, effective, and patient-centered care practices tailored to the demographic’s unique healthcare needs. Ultimately, the research aspires to create a lasting impact on the quality of geriatric care.

This progressive strategy also resonates with broader healthcare trends that advocate for individualized medicine. By recognizing that older individuals often have unique health profiles, including differing metabolic responses to drugs, there is a collective response from the healthcare community toward more personalized and precise prescribing.

In conclusion, the development of this practice tool marks a pivotal step towards refining medication management in the geriatric population. Through a blend of innovative redesigns and collaborative input, researchers are paving the way for enhanced usability and effectiveness of the STOPP/START criteria. As this tool gains traction among healthcare professionals, the landscape of geriatric care could witness substantial improvements, illustrating how refined tools can lead to safer practices that elevate patient care standards across the board.

Subject of Research: Usability of STOPP/START criteria for elderly medication management.

Article Title: Improving usability of the STOPP/START version 3 criteria: development of a practice tool for clinicians, students and researchers.

Article References:

Dalleur, O., Sibille, F.X., Mouzon, A. et al. Improving usability of the STOPP/START version 3 criteria: development of a practice tool for clinicians, students and researchers.
Eur Geriatr Med 16, 1403–1413 (2025). https://doi.org/10.1007/s41999-025-01214-y

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s41999-025-01214-y

Keywords: STOPP, START, medication management, geriatrics, usability, healthcare, polypharmacy, clinical practice.